Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 | Zendy

Michael J. Joyner | Zendy; Rickey E. Carter | Zendy; Jonathon W. Senefeld | Zendy; Stephen A. Klassen | Zendy; John R. Mills | Zendy; Patrick W. Johnson | Zendy; Elitza S. Theel | Zendy; Chad C. Wiggins | Zendy; Katelyn A. Bruno | Zendy; Allan M. Klompas | Zendy; Elizabeth R. Lesser | Zendy; Katie L. Kunze | Zendy; Matthew A. Sexton | Zendy; Juan C. Diaz Soto | Zendy; Sarah E. Baker | Zendy; John R.A. Shepherd | Zendy; Noud van Helmond | Zendy; Nicole Verdun | Zendy; Peter Marks | Zendy; Camille M. van Buskirk | Zendy; Jeffrey L. Winters | Zendy; James R. Stubbs | Zendy; Robert F. Rea | Zendy; David O. Hodge | Zendy; Vitaly Herasevich | Zendy; Emily R. Whelan | Zendy; Andrew J. Clayburn | Zendy; Kathryn F. Larson | Zendy; Juan G. Ripoll | Zendy; Kylie J. Andersen | Zendy; Matthew Buras | Zendy; Matthew N.P. Vogt | Zendy; Joshua J. Dennis | Zendy; Riley J. Regimbal | Zendy; Philippe R. Bauer | Zendy; Janis E. Blair | Zendy; Nigel Paneth | Zendy; DeLisa Fairweather | Zendy; R. Scott Wright | Zendy; Arturo Casadevall | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Author(s) -

Michael J. Joyner,

Rickey E. Carter,

Jonathon W. Senefeld,

Stephen A. Klassen,

John R. Mills,

Patrick W. Johnson,

Elitza S. Theel,

Chad C. Wiggins,

Katelyn A. Bruno,

Allan M. Klompas,

Elizabeth R. Lesser,

Katie L. Kunze,

Matthew A. Sexton,

Juan C. Diaz Soto,

Sarah E. Baker,

John R.A. Shepherd,

Noud van Helmond,

Nicole Verdun,

Peter Marks,

Camille M. van Buskirk,

Jeffrey L. Winters,

James R. Stubbs,

Robert F. Rea,

David O. Hodge,

Vitaly Herasevich,

Emily R. Whelan,

Andrew J. Clayburn,

Kathryn F. Larson,

Juan G. Ripoll,

Kylie J. Andersen,

Matthew Buras,

Matthew N.P. Vogt,

Joshua J. Dennis,

Riley J. Regimbal,

Philippe R. Bauer,

Janis E. Blair,

Nigel Paneth,

DeLisa Fairweather,

R. Scott Wright,

Arturo Casadevall

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2031893

Subject(s) - convalescent plasma , covid-19 , virology , antibody , medicine , immunology , outbreak , disease , infectious disease (medical specialty)

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research